New somatostatin molecule for management of endocrine tumours.

This publication has 17 references indexed in Scilit:

• Treatment of patients with pancreatic endocrine tumours using a new long-acting somatostatin analogue symptomatic and peptide responses.
  Gut, 1985
• Evaluation of antisecretory drug therapy of zollinger-ellison syndrome (ZES) using 24-hour pH monitoring
  Digestive Diseases and Sciences, 1983
• Somatostatinoma syndrome. Clinical, morphological and metabolic features and therapeutic aspects
  Journal of Molecular Medicine, 1983
• Effect of somatostatin on diarrhea and on small intestinal water and electrolyte transport in a patient with pancreatic cholera
  Digestive Diseases and Sciences, 1982
• RAPID IMPROVEMENT OF SKIN LESIONS IN GLUCAGONOMAS WITH INTRAVENOUS SOMATOSTATIN INFUSION
  The Lancet, 1980
• REBOUND EFFECT AFTER SOMATOSTATIN TREATMENT IN VERNER-MORRISON SYNDROME
  The Lancet, 1979
• The Carcinoid Flush
  New England Journal of Medicine, 1978
• LOWERING OF BASAL AND STIMULATED SERUM IMMUNOREACTIVE GASTRIN AND GASTRIC SECRETION IN PATIENTS WITH ZOLLINGER-ELLISON SYNDROME BY SOMATOSTATIN
  Acta Endocrinologica, 1975
• Somatostatin Inhibition of Insulin and Gastrin Hypersecretion in Pancreatic Islet-Cell Carcinoma
  New England Journal of Medicine, 1975
• INHIBITION OF GASTRIN AND GASTRIC-ACID SECRETION BY GROWTH-HORMONE RELEASE-INHIBITING HORMONE
  The Lancet, 1974